TY  - GEN
AU  - Edden,Y
AU  - Wexner,S D
AU  - Berho,M
TI  - The use of molecular markers as a method to predict the response to neoadjuvant therapy for advanced stage rectal adenocarcinoma
SN  - 1463-1318
PY  - 2012///0815
KW  - Adenocarcinoma
KW  - metabolism
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antimetabolites, Antineoplastic
KW  - therapeutic use
KW  - Apoptotic Protease-Activating Factor 1
KW  - Biomarkers, Tumor
KW  - Chemoradiotherapy
KW  - Chi-Square Distribution
KW  - Cyclin-Dependent Kinase Inhibitor p21
KW  - Cyclin-Dependent Kinase Inhibitor p27
KW  - Cyclooxygenase 2
KW  - Dose Fractionation, Radiation
KW  - Female
KW  - Fluorouracil
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Multivariate Analysis
KW  - Neoadjuvant Therapy
KW  - Neoplasm Staging
KW  - Proto-Oncogene Proteins c-bcl-2
KW  - Rectal Neoplasms
KW  - Statistics, Nonparametric
KW  - Tumor Suppressor Protein p53
KW  - Vascular Endothelial Growth Factor A
KW  - bcl-2-Associated X Protein
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1111/j.1463-1318.2011.02697.x
ER  -